Now showing items 1-2 of 2
Considerations into pharmacogenomics of COVID-19 pharmacotherapy: hope, hype and reality
(Academic Press, 2022)
COVID-19 medicines, such as molnupiravir are beginning to emerge for public health and clinical practice. On the other hand, drugs display marked variability in their efficacy and safety. Hence, COVID-19 medicines, as with ...
The long view on COVID-19 theranostics and oral antivirals: living with endemic disease and lessons from molnupiravir
The long view on living with COVID-19 as an endemic disease calls for expanding the planetary health inter-vention toolbox. We will need a battery of vaccines, small molecule oral antiviral drugs, and biomarkers toforecast ...